Log In
person
Celltrion Pharm Inc
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2018
| Reporting Segmentarrow_drop_up | Product Line | Amount | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount | Percentage |
| BioPharmaceutical Medicines |
Biosimilars; sold through distributor
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
861.88M | 86.07% |
| Chemical Medicines |
Biosimilars; sold through distributor
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
139.47M | 13.93% |
| keyboard_arrow_down |
BioPharmaceutical Medicines
Biosimilars; sold through distributor
|
861.88M | 86.07% |
| keyboard_arrow_right |
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
||
| keyboard_arrow_down |
Chemical Medicines
Biosimilars; sold through distributor
|
139.47M | 13.93% |
| keyboard_arrow_right |
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
||